Regulatory Domain Head, Medical Devices Business, Wipro
Pavan Kumar Garikapati is a Regulatory, Quality and IT Compliance professional with about 20 years of experience. Pavan currently heads Regulatory domain practice for Medical Devices business unit at Wipro. He has expertise in US, Europe and emerging market medical device regulations. Pavan is a Six Sigma Master Black belt and Certified Lead Auditor. He has spoken at various conferences and authored papers on these topics.
Posted by: Pavan Kumar Garikapati | August 25, 2015
The medical devices industry forms a miniscule 6.4% of the Indian healthcare sector. Of course, it is growing faster than the entire healthcare sector put together, but that is little consolation when local players continue to of scalability, credibility and brand value. I have always felt that the government wasn’t doing enough to support the industry.
Posted by: Pavan Kumar Garikapati | October 10, 2014
Post market surveillance (PMS) is a regulatory requirement set in place by the US Food and Drug Administration (FDA) and other regulatory bodies to monitor the continued safety and effectiveness of medical devices once they are in use in the market. This is important to ensure that these devices do not pose any unknown danger or cause harm to patients.
© 2021 Wipro Limited |
|
© 2021 Wipro Limited |
Pharmaceutical & Life Sciences